Novel Coronavirus (SARS-CoV-2/COVID-19)
Statement from the AHA, AMA, ANA as coronavirus deaths in U.S. tops 200,000.
Strategy and innovation leaders from hospitals and health systems across the country recently came together to share lessons learned and plans for the future as the field moves from response through recovery and on to rebuilding. The virtual 鈥淣avigating a New Reality鈥 program Sept. 14-16 from the鈥
The Federal Reserve Board updated its FAQs on the Main Street Lending Program to clarify its expectations for nonprofit and other facilities regarding lender underwriting.
From the beginning of the COVID-19 pandemic, hospitals have kept patients safe in the face of rapidly evolving scientific evidence and daunting resource limitations. A recent article in the Wall Street Journal on the spread of COVID-19 infections in hospitals does not give a full picture and proper鈥
AHA is launching a COVID-19 vaccine resource hub to support hospitals and health systems.
Today, we continue to grapple not only with the COVID-19 pandemic, but also a dangerously polarized election, ongoing civil unrest in the face of untenable systemic racism 鈥 and now, 94 major wildfires that are devastating our West Coast neighbors, families and friends, as well as recent hurricanes鈥
The AHA requests that the Department of Health and Human Services revise certain FAQs that place problematic restrictions on the use of some CARES Act Provider Relief Fund dollars.
The Department of Health and Human Services鈥 Office of the Assistant Secretary for Preparedness and Response recently posted new and updated COVID-19 resources at its Technical Resources, Assistance Center, and Information Exchange.
The Food and Drug Administration approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and mechanically ventilated patients in an intensive-care setting and of non-intubated patients prior to and/or during surgical and other procedures.
The National Institutes of Health awarded $12 million to non-profit research institution RTI International for outreach and engagement efforts in ethnic and racial minority communities that have been disproportionately affected by the COVID-19 pandemic.